SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Medicamen Biotech acquires factory land in Q2FY18

10 Nov 2017 Evaluate

Medicamen Biotech has acquired factory land (build up area of 35000 sq ft) adjoining to the existing manufacturing unit at Haridwar for future expansion during July-September 2017 quarter (Q2 FY18)

Medicamen Biotech is engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets.


Medicamen Biotech Share Price

284.05 -5.55 (-1.92%)
11-May-2026 11:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1878.00
Dr. Reddys Lab 1289.40
Cipla 1342.00
Zydus Lifesciences 947.55
Lupin 2244.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×